Today, the market continues to shrink and adjust. As of the close, the Prev is down 0%.Freespinsnodeposit.61%, the Shenzhen Index fell 1.35%, and the gem Index fell 1.45%. The market began to rise before the festival, with the Prev hitting an intraday high of 3151 points. After a rebound, the market began to adjust slightly in the past two days.

Sister F also said before that this wave of rebound, northbound funds played a very important role, and these two days northward capital outflow occurred a small situation. Coincidentally, the RMB has also depreciated slightly in the past two days, which may also have a certain impact on foreign capital inflows.

However, on the whole, the market trend is still very sound, F sister is relatively optimistic, I believe that after the shock, the market can develop for the better.

Today, the concept of cellular immunotherapy is surging against the market.

On the news side, according to the international journal Cell DiscoveryFreespinsnodepositChinese scientists have successfully cured a type 2 diabetic patient with severely impaired islet function by using autologous regenerated islet transplantation derived from stem cells for the first time in the world. At present, the patient has been completely separated from insulin for 33 months.

Although it seems that hot spots in the market are constantly switching, in fact, one of the biggest main lines this year is new quality productivity. Whether it is cellular immunotherapy, or synthetic biology, low-altitude economy, quantum technology and other hot spots, the logic behind it is new productivity, which is the representative of high-tech, high-efficiency, high-quality, high-efficiency and sustainable productivity.

Friends who have been reading the articles of Sister F know that when the index was near 3000 points, Sister F often mentioned the CSI 300 Index to everyone. The optimistic logic is clear that when the market is low, we can pay more attention to this kind of wide-base index, because once the index rises, the core wide-base index such as the CSI 300 will not perform badly.

And now the index is above 3100 points, if the short-term index continues to break through upward pressure, at this time the layout direction, might as well think more about the low level of industry segments.

For example, the field of innovative drugs mentioned by Sister F on Monday, whether it is today's concept of cellular immunotherapy or the concept of synthetic biology, is closely related to innovation in the field of medicine, and innovative drugs are also representatives of new productivity. Sister F believes that under the background of policy support and continuous improvement of industry fundamentals, innovative drugs may have good investment value in the future.

Friends who are interested in the innovative drug sector might as well pay more attention to the innovative drug ETF (code: 159858).

Risk hint: the fund is risky and the investment should be cautious. Public offering securities investment fund (hereinafter referred to as "fund") is a long-term investment tool, its main function is to diversify investment and reduce individual risks caused by investing in a single securities. Funds are different from financial instruments such as bank savings, which can provide fixed income expectations. when you buy fund products, you may not only share the income generated by the fund investment according to your share, but also bear the losses caused by the fund investment. Before you make an investment decision, please carefully read the product legal documents such as fund contract, fund prospectus and summary of fund product information, and this risk disclosure book, so as to fully understand the risk-return characteristics and product characteristics of the fund. Seriously consider the various risk factors existing in the fund, and fully consider your own risk tolerance according to your own investment purpose, investment period, investment experience, asset status and other factors. On the basis of understanding the product situation and sales appropriateness opinions, rational judgment and careful investment decisions are made. According to the relevant laws and regulations, Southern Fund Management Co., Ltd. made the following risk revelation: first, according to the different investment objects, funds are divided into stock funds, mixed funds, bond funds, money market funds, funds in funds, commodity funds and other different types of funds, you invest in different types of funds will get different returns expected, will also bear different degrees of risk. In general, the higher the expected return of the fund, the greater the risk you take. Second, the fund may face all kinds of risks in the process of investment operation, including not only market risk, but also fund management risk, technical risk and compliance risk. A huge redemption risk is a risk unique to open-end funds, that is, when the net redemption application of a single open-end fund exceeds a certain proportion of the total share of the fund (10% for open-end funds and 20% for regular open-end funds, except for the special products prescribed by the CSRC), you may not be able to redeem all the fund shares you have applied for in time, or the payment of your redemption may be delayed. Third, you should fully understand the difference between regular fixed investment and zero deposit and withdrawal of the fund. Regular quota investment is a simple and easy way to guide investors to make long-term investment and average investment cost, but it can not avoid the risks inherent in fund investment and can not guarantee investors to obtain returns. it is not an equivalent way of financial management instead of savings. Fourth, the fund manager undertakes to manage and use the fund assets in good faith and diligence, but does not guarantee the profit of the fund or the minimum return. The fund's past performance and its net worth do not predict its future performance, which is managed by fund managers.FreespinsnodepositThe performance of his fund does not constitute a guarantee of the performance of the fund. Southern Fund Management Co., Ltd. reminds you of the "buyer's responsibility" principle of fund investment. After making an investment decision, you will bear the investment risk caused by the change of fund operation and fund net worth. Fund managers, fund custodians, fund sales institutions and relevant institutions do not make any commitment or guarantee to the investment income of the fund. 5. The innovative drug ETF (code: 159858) shall be raised by Southern Fund Management Co., Ltd. (hereinafter referred to as "fund manager") in accordance with relevant laws, regulations and agreements, and shall be registered with the permission of the China Securities Regulatory Commission (hereinafter referred to as "CSRC"). The fund contract, fund prospectus and fund product information summary of the fund have been obtained through the fund electronic disclosure website of China Securities Regulatory Commission [httpFreespinsnodeposit://eid.csrc.gov.cn/fund] and the fund manager's website [www.nffund.com] made public disclosure. The registration of the Fund by the China Securities Regulatory Commission does not indicate that it has made substantial judgments or guarantees on the investment value, market prospects and returns of the Fund, nor does it indicate that there is no risk in investing in the Fund. The comment area does not represent the opinions of the public account on the "Great ETF". The above contents are only personal opinions and do not represent the official opinions and positions of the institution. The opinions and contents may change or be updated in the future. We strive for but do not guarantee the accuracy and integrity of the contents. Funds are risky and investment must be cautious.